Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Elias

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Malaria Journal|January 29, 2015
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studiesSusanne H Hodgson, Alexander D Douglas, Nick J Edwards, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2014
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trialSusanne H Hodgson, Prateek Choudhary, Sean C Elias, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Plos One|February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Circulation|November 3, 2016
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular DamageThiago Bruder-Nascimento, Nathanne S Ferreira, Camila Z Zanotto, et al.
The Journal of Infectious Diseases|January 26, 2012
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vectorGeraldine A O'Hara, Christopher J A Duncan, Katie J Ewer, et al.
The Science of the Total Environment|June 25, 2013
Least Disturbed Condition for European Mediterranean riversM J Feio, F C Aguiar, S F P Almeida, et al.
Frontiers in Immunology|August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human TrialHans de Graaf, Ruth O Payne, Iona Taylor, et al.
Cell Reports|April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated HumansPramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
Nature Communications|November 29, 2013
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisationKatie J Ewer, Geraldine A O'Hara, Christopher J A Duncan, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Malaria Journal|January 29, 2015
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studiesSusanne H Hodgson, Alexander D Douglas, Nick J Edwards, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2014
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trialSusanne H Hodgson, Prateek Choudhary, Sean C Elias, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Plos One|February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Circulation|November 3, 2016
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular DamageThiago Bruder-Nascimento, Nathanne S Ferreira, Camila Z Zanotto, et al.
The Journal of Infectious Diseases|January 26, 2012
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vectorGeraldine A O'Hara, Christopher J A Duncan, Katie J Ewer, et al.
The Science of the Total Environment|June 25, 2013
Least Disturbed Condition for European Mediterranean riversM J Feio, F C Aguiar, S F P Almeida, et al.
Frontiers in Immunology|August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human TrialHans de Graaf, Ruth O Payne, Iona Taylor, et al.
Cell Reports|April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated HumansPramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
Nature Communications|November 29, 2013
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisationKatie J Ewer, Geraldine A O'Hara, Christopher J A Duncan, et al.
Pageof 19